Search is Powered by Google
Urology / Nephrology News

Multi-Institutional Evaluation Of The Predictive Value Of P53 Immunohistochemical Staining In Patients With PT1-2 No Disease At Radical Cystectomy

Main Category: Urology / Nephrology
Also Included In: Cancer / Oncology;  Conferences;  Clinical Trials / Drug Trials
Article Date: 09 Jun 2008 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

ORLANDO, FL (UroToday.com) - The authors tested whether p53 expression could predict disease recurrence and disease-specific survival after radical cystectomy in patients with pT1-2N0M0 urothelial carcinoma of the bladder (UCB). They evaluated 272 patients from five centers who had pT1-2N0M0 bladder cancer treated with radical cystectomy and bilateral lymphadenectomy (median follow-up: 5 and 12 years, respectively). None of the patients received neoadjuvant or adjuvant chemotherapy.

Overall, 33.5% of patients had altered expression of p53 (p53alt) and 18% died of bladder cancer. In multivariate analyses, patients with p53alt tumors had a significantly increased hazard ratio for both disease recurrence (4.88; p<0.001) and cancer-specific mortality (4.91, p<0.001).p53 status and lymph vascular invasion were both predictive of disease recurrence and cancer-specific mortality after adjusting for other risk factors. Addition of p53 increased the predictive ability of models based on age, gender, pT1 vs pT2 stage, tumor grade, lympho-vascular invasion, number of lymph nodes removed, and concomitant carcinoma in situ for disease recurrence and cancer-specific mortality by 9.2% (60.8% versus 70.0%, p<0.001) and 9.5% (63.4% versus 72.9, p<0.001), respectively. 60% of the p53alt patients were free of disease at 5 years compared to 15% of the p53 normal patients.

The authors concluded that assessment of p53 in bladder cancer specimens improves the prediction of disease recurrence and survival in patients with pT1-2N0M0 disease treated by radical cystectomy. These findings suggest that evaluation of p53 could help identify patients who may benefit from adjuvant treatment after radical cystectomy.

Presented by Shahrokh F Shariat, et.al., MD at the Annual Meeting of the American Urological Association (AUA) - May 17 - 22, 2008. Orange County Convention Center - Orlando, Florida, USA.

Reported by UroToday.com Contributing Editor David P. Wood, MD

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2008 - UroToday




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
40Over40: A New Campaign To Tackle Low Awareness Of Erectile Dysfunction And Its Health Implications In Younger Men
24 Jun 2008
A new survey of 1,000 men aged over 40, commissioned by Eli Lilly and Company Limited (Lilly UK) as part of a new erectile dysfunction awareness campaign, 40over40, reveals that just over 10% of men in their early 40s are...


Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

View more videos...